These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 11151402

  • 1. Inhaled fluticasone propionate. A pharmacoeconomic review of its use in the management of asthma.
    Lamb HM, Culy CR, Faulds D.
    Pharmacoeconomics; 2000 Nov; 18(5):487-510. PubMed ID: 11151402
    [Abstract] [Full Text] [Related]

  • 2. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA, Plosker GL.
    Pharmacoeconomics; 2003 Nov; 21(13):951-89. PubMed ID: 12959627
    [Abstract] [Full Text] [Related]

  • 3. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B, Faulds D.
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [Abstract] [Full Text] [Related]

  • 4. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
    Markham A, Adkins JC.
    Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
    [Abstract] [Full Text] [Related]

  • 5. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS.
    Drugs; 2003 Dec; 63 Suppl 2():1-20. PubMed ID: 14984077
    [Abstract] [Full Text] [Related]

  • 6. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A, Jarvis B.
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [Abstract] [Full Text] [Related]

  • 7. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children.
    Barnes NC, Thwaites RM, Price MJ.
    Respir Med; 1999 Jun; 93(6):402-7. PubMed ID: 10464822
    [Abstract] [Full Text] [Related]

  • 8. Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma.
    Volmer T, Kielhorn A, Weber HH, Wiessmann KJ.
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):525-31. PubMed ID: 10662477
    [Abstract] [Full Text] [Related]

  • 9. Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma.
    Menendez R, Stanford RH, Edwards L, Kalberg C, Rickard K.
    Pharmacoeconomics; 2001 Nov; 19(8):865-74. PubMed ID: 11596838
    [Abstract] [Full Text] [Related]

  • 10. Cost-efficacy comparison of inhaled fluticasone propionate and budesonide in the treatment of asthma.
    Stempel DA, Stanford RH, Thwaites R, Price MJ.
    Clin Ther; 2000 Dec; 22(12):1562-74. PubMed ID: 11192147
    [Abstract] [Full Text] [Related]

  • 11. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD, Nelson H, Borker R, Emmett A, Jhingran P, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2004 Dec; 22(12):815-25. PubMed ID: 15294013
    [Abstract] [Full Text] [Related]

  • 12. A cost-effectiveness analysis of first-line controller therapies for persistent asthma.
    Shih YC, Mauskopf J, Borker R.
    Pharmacoeconomics; 2007 Dec; 25(7):577-90. PubMed ID: 17610338
    [Abstract] [Full Text] [Related]

  • 13. Fluticasone propionate compared with zafirlukast in controlling persistent asthma: a randomized double-blind, placebo-controlled trial.
    Busse W, Wolfe J, Storms W, Srebro S, Edwards L, Johnson M, Bowers BW, Rogenes PR, Rickard K.
    J Fam Pract; 2001 Jul; 50(7):595-602. PubMed ID: 11485708
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Jul; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 15. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
    Sorkness CA, LaForce C, Storms W, Lincourt WR, Edwards L, Rogenes PR.
    Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
    [Abstract] [Full Text] [Related]

  • 16. Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
    O'Connor RD, Stanford R, Crim C, Yancey SW, Edwards L, Rickard KA, Dorinsky P.
    Ann Allergy Asthma Immunol; 2004 Dec; 93(6):581-8. PubMed ID: 15609769
    [Abstract] [Full Text] [Related]

  • 17. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB, Nelson HS, Stricker WE, Raff H, Newman KB.
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [Abstract] [Full Text] [Related]

  • 18. Economic impact of asthma therapy with fluticasone propionate, montelukast, or zafirlukast in a managed care population.
    Pathak DS, Davis EA, Stanford RH.
    Pharmacotherapy; 2002 Feb; 22(2):166-74. PubMed ID: 11837555
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus babyhaler spacer in the treatment of asthma in preschool-aged children.
    Bisgaard H, Price MJ, Maden C, Olsen NA.
    Chest; 2001 Dec; 120(6):1835-42. PubMed ID: 11742910
    [Abstract] [Full Text] [Related]

  • 20. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma.
    Reynolds NA, Lyseng-Williamson KA, Wiseman LR.
    Drugs; 2005 Dec; 65(12):1715-34. PubMed ID: 16060707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.